Literature DB >> 11557733

Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression.

I Kim1, S O Moon, S K Park, S W Chae, G Y Koh.   

Abstract

Vascular endothelial growth factor (VEGF) and angiopoietin-1 (Ang1) are potent vasculogenic and angiogenic factors that hold promise as a means to produce therapeutic vascularization and angiogenesis. However, VEGF also acts as a proinflammatory cytokine by inducing adhesion molecules that bind leukocytes to endothelial cells, an initial and essential step toward inflammation. In the present study, we used human umbilical vascular endothelial cells (HUVECs) to examine the effect of Ang1 on VEGF-induced expression of three adhesion molecules: intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin. Interestingly, Ang1 suppressed VEGF-induced expression of these adhesion molecules. Furthermore, Ang1 reduced VEGF-induced leukocyte adhesion to HUVECs. These results demonstrate that Ang1 counteracts VEGF-induced inflammation by reducing VEGF-induced endothelial adhesiveness.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557733     DOI: 10.1161/hh1801.097034

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  111 in total

1.  Sugar creates a sticky business: round up the usual suspects.

Authors:  James T Rosenbaum
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

2.  Angiopoietin-1 and vascular endothelial growth factor regulation of leukocyte adhesion to endothelial cells: role of nuclear receptor-77.

Authors:  Hodan Ismail; Mahroo Mofarrahi; Raquel Echavarria; Sharon Harel; Eric Verdin; Hyung W Lim; Zheng-Gen Jin; Jianxin Sun; Huiyan Zeng; Sabah N A Hussain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-24       Impact factor: 8.311

3.  Angiopoietin-2-driven vascular remodeling in airway inflammation.

Authors:  Sebastien P Tabruyn; Katharine Colton; Tohru Morisada; Jonas Fuxe; Stanley J Wiegand; Gavin Thurston; Anthony J Coyle; Jane Connor; Donald M McDonald
Journal:  Am J Pathol       Date:  2010-10-15       Impact factor: 4.307

4.  Regulation of adhesion by vascular endothelial growth factor in HaCaT cells.

Authors:  Chunming Li; Xiaoyong Man; Wei Li; Jiong Zhou; Jiaqi Chen; Suiqing Cai; Min Zheng
Journal:  Mol Cell Biochem       Date:  2010-09-28       Impact factor: 3.396

Review 5.  Mediators of ocular angiogenesis.

Authors:  Yureeda Qazi; Surekha Maddula; Balamurali K Ambati
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

Review 6.  Targeting microvasculature for neuroprotection after SCI.

Authors:  Janelle M Fassbender; Scott R Whittemore; Theo Hagg
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

Review 7.  Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.

Authors:  Hellmut G Augustin; Gou Young Koh; Gavin Thurston; Kari Alitalo
Journal:  Nat Rev Mol Cell Biol       Date:  2009-03       Impact factor: 94.444

8.  Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment.

Authors:  Sirpa Loukovaara; Kaisa Lehti; Alexandra Robciuc; Timo Pessi; Juha M Holopainen; Katri Koli; Ilkka Immonen; Jorma Keski-Oja
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-12       Impact factor: 3.117

Review 9.  Tie2 is tied at the cell-cell contacts and to extracellular matrix by angiopoietin-1.

Authors:  Shigetomo Fukuhara; Keisuke Sako; Kazuomi Noda; Kaori Nagao; Koichi Miura; Naoki Mochizuki
Journal:  Exp Mol Med       Date:  2009-03-31       Impact factor: 8.718

10.  Expression patterns of angiopoietin-1, -2, and tie-2 receptor in ulcerative colitis support involvement of the angiopoietin/tie pathway in the progression of ulcerative colitis.

Authors:  Ayumi Yoshizaki; Toshiyuki Nakayama; Shinji Naito; Ichiro Sekine
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.